Nanotechnology: an emerging approach to combat COVID-19

被引:34
作者
Chintagunta, Anjani Devi [1 ]
Krishna, Sai M. [1 ]
Nalluru, Sanjana [1 ]
Kumar, Sampath N. S. [1 ]
机构
[1] Vignans Fdn Sci Technol & Res, Dept Biotechnol, Vadlamudi 522213, Andhra Pradesh, India
关键词
COVID-19; Diagnosis; Nanotechnology; SARS-CoV-2; Treatment; Vaccines;
D O I
10.1007/s42247-021-00178-6
中图分类号
T [工业技术];
学科分类号
08 ;
摘要
The recent outbreak of coronavirus disease (COVID-19) has challenged the survival of human existence in the last 1 year. Frontline healthcare professionals were struggling in combating the pandemic situation and were continuously supported with literature, skill set, research activities, and technologies developed by various scientists/researchers all over the world. To handle the continuously mutating severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requires amalgamation of conventional technology with emerging approaches. Nanotechnology is science, engineering, and technology dealing at the nanoscale level. It has made possible the development of nanomaterials, nano-biosensors, nanodrugs, and vaccines for diagnosis, therapy, and prevention of COVID-19. This review has elaborately highlighted the role of nanotechnology in developing various detection kits such as nanoparticle-assisted diagnostics, antibody assay, lateral flow immunoassay, nanomaterial biosensors, etc., in detection of SARS-CoV-2. Similarly, various advancements supervene through nanoparticle-based therapeutic drugs for inhibiting viral infection by blocking virus attachment/cell entry, multiplication/replication, and direct inactivation of the virus. Furthermore, information on vaccine development and the role of nanocarriers/nanoparticles were highlighted with a brief outlining of nanomaterial usage in sterilization and preventive mechanisms engineered to combat COVID-19 pandemic.
引用
收藏
页码:119 / 130
页数:12
相关论文
共 79 条
[71]   Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2 [J].
Uzunova, Katya ;
Filipova, Elena ;
Pavlova, Velichka ;
Vekov, Toni .
BIOMEDICINE & PHARMACOTHERAPY, 2020, 131
[72]  
van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1101/2020.03.09.20033217, 10.1056/NEJMc2004973]
[73]   Inactivation of common hospital acquired pathogens on surfaces and in air utilizing engineered water nanostructures (EWNS) based nano-sanitizers [J].
Vaze, Nachiket ;
Pyrgiotakis, Georgios ;
McDevitt, James ;
Mena, Lucas ;
Melo, Adler ;
Bedugnis, Alice ;
Kobzik, Lester ;
Eleftheriadou, Mary ;
Demokritou, Philip .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 18 :234-242
[74]  
World Health Organisation (WHO), 2020, COVID-19 weekly epidemiological update-December 6
[75]  
World Health Organization, 2020, Draft landscape of COVID-19 candidate vaccines
[76]  
Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1007/s40820-020-00498-y, 10.1038/s41368-020-0074-x, 10.1038/s41368-020-0074-X]
[77]   Role of metal and metal oxide nanoparticles as diagnostic and therapeutic tools for highly prevalent viral infections [J].
Yadavalli, Tejabhiram ;
Shukla, Deepak .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2017, 13 (01) :219-230
[78]   Selective Adsorption and Photocatalytic Degradation of Extracellular Antibiotic Resistance Genes by Molecularly-Imprinted Graphitic Carbon Nitride [J].
Yuan, Qingbin ;
Zhang, Danning ;
Yu, Pingfeng ;
Sun, Ruonan ;
Javed, Hassan ;
Wu, Gang ;
Alvarez, Pedro J. J. .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2020, 54 (07) :4621-4630
[79]  
Zhao Zhilei., 2020, bioRxiv, DOI 10.1101/2020.02.22.961268